Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
6(43%)
Results Posted
60%(3 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_2
1
7%
Ph phase_1
2
14%
Ph not_applicable
3
21%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

6

trials recruiting

Total Trials

14

all time

Status Distribution
Active(6)
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Recruiting5
Terminated2
Active, not recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
6
Success Rate
71.4%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
N/A3 (50.0%)

Trials by Status

completed536%
terminated214%
recruiting536%
active_not_recruiting17%
suspended17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT02320656Not Applicable

Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015

Completed
NCT06514261Phase 1

Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

Recruiting
NCT06888323Phase 1

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment

Suspended
NCT04263181

AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration

Active Not Recruiting
NCT02958462Not Applicable

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Recruiting
NCT04154553

Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure

Recruiting
NCT05324553

Patient Derived Preclinical Models

Recruiting
NCT02604563

Aging, Geriatric Syndromes and Clonal Hematopoiesis

Recruiting
NCT02297009

Comparison of the Methylation Pattern of DNA in Buccal Swabs From Different Time Points

Terminated
NCT03063203Phase 2

Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia

Terminated
NCT02787616

Genetic Basis of Rosacea

Completed
NCT00277433

Histamine Pharmacogenetics in Children With Atopic Dermatitis

Completed
NCT00384241

Evaluating the Relationship Between Inflammation, Genetics, and Stress in the Development of High Blood Pressure

Completed
NCT01016106Not Applicable

Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population

Completed

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14